Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils

Helicobacter

Volumn 13, Issue 1, 2008, Pages 20-29

  Li, Guo Qing ^a,b,c   Xia, Harry H X ^b   Chen, Min Hu ^a   Tsukamoto, Tetsuya ^d   Tatematsu, Masae ^d   Gu, Qing ^b   Qiao, Liang ^b   Cho, C H ^b   So, Wallace H L ^b   Yuen, M F ^b   Hu, Pin Jin ^a   Liang, Ying Jie ^a   Lin, Han Liang ^a   Chan, Annie O O ^b   Wong, Benjamin C Y ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF SOUTH CHINA   (China)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Apoptosis; Aspirin; Cell proliferation; H. pylori infection; Heterotopic proliferative glands; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; GASTRITIS; GERBIL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; STOMACH EPITHELIUM; STOMACH GLAND;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ASPIRIN; CHORISTOMA; DINOPROSTONE; EPITHELIAL CELLS; GASTRIC MUCOSA; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HYPERPLASIA; INFLAMMATION; MALE;

ANIMALIA; HELICOBACTER PYLORI; MERIONES UNGUICULATUS;

EID: 38149120253     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2008.00585.x     Document Type: Article

References (45)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori: Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994 61 : 1 241.
2. Fan XG, Kelleher D, Fan XJ, Xia HX, Keeling PW. Helicobacter pylori increases proliferation of gastric epithelial cells. Gut 1996 38 : 19 22.
3. Lynch DA, Mapstone NP, Clarke AM, Sobala GM, Jackson P, Morrison L, Dixon MF, Quirke P, Axon AT. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995 36 : 346 50.
4. Lynch DA, Mapstone NP, Clarke AM, Jackson P, Dixon MF, Quirke P, Axon AT. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut 1995 36 : 351 53.
5. Cahill RJ, Kilgallen C, Beattie S, Hamilton H, O'Morain C. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 1996 38 : 177 81.
6. Solcia E, Fiocca R, Luinetti O, Villani L, Padovan L, Calistri D, Ranzani GN, Chiaravalli A, Capella C. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996 20 : S8 22.
7. Anti M, Armuzzi A, Gasbarrini A, Gasbarrini G. Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis. Gut 1998 43 (Suppl. 1 S27 S32.
8. Correa P, Miller MJS. Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 1998 54 : 151 162.
9. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ET, Mera R, Miller MJ, Correa P. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996 56 : 3238 3243.
10. Moss S F, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996 38 : 498 501.
11. Ierardi E, Francavilla A, Balzano T, Traversa A, Principi M, Monno RA, Amoruso A, Ingrosso M, Pisani A, Panella C. Effect of Helicobacter pylori eradication on gastric epithelial proliferation, relationship with ras oncogene p21 expression. Ital J Gastroenterol Hepatol 1997 29 : 214 9.
12. Que FG, Gores GJ. Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 1996 110 : 1238 43.
13. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001 96 : 16 26.
14. Nozaki K, Shimizu N, Tsukamoto T, Inada K, Cao X, Ikehara Y, Kaminishi M, Sugiyama A, Tatematsu M. Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori-infected Mongolian gerbils on eradication. Jpn J Cancer Res 2002 93 : 374 81.
15. Tsukamoto T, Nozaki K, Tatematsu M. Mechanism of Helicobacter pylori induced stomach carcinogenesis - analysis using animal models. Nippon Rinsbo 2003 61 : 56 60.
16. Cao X, Tsukamoto T, Nozaki K, Shimizu N, Mizoshita T, Kumagai T, Kaminishi M, Tatematsu M. Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils. Cancer Sci 2004 95 : 872 77.
17. Moran EM. Epidemiological and clinical aspects of nonsteroidal antiinflammatory drugs and cancer risks. J Environ Pathol Toxical Oncol 2002 21 : 193 201.
18. Shaheen NJ, Straus WL, Sandler RS. Chemoprevention of gastrointestinal malignancies with nonsteroidal anti-inflammatory drugs. Cancer 2002 94 : 950 63.
19. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2003 95 : 1784 91.
20. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997 112 : 1386 97.
21. Barnes CJ, Lee M. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin. Gastroenterology 1998 114 : 873 7.
22. Lee M, Cryer B, Feldman M. dose effects of aspirin on gastric prostaglandins and stomach mucosal injury. Ann Intern Medical 1994 120 : 184 89.
23. Li GQ, Xia HH, Chen MH, et al. Effects of cyclooxygenase-1 and -2 gene disruption on Helicobacter pylori-induced gastric inflammation. J Infect Dis 2006 193 : 1037 46.
24. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. Am J Surg Pathol 1996 20 : 1161 81.
25. Shirin H, Moss SF, Kancherla S, Kancherla K, Holt PR, Weinstein IB, Sordillo EM. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori. J Gastroenterol Hepatol 2006 21 : 1388 93.
26. Wang WH, Wong WM, Dailidiene D, Berg DE, Gu Q, Lai KC, Lam SK, Wong BC. Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents. Gut 2003 52 : 490 5.
27. Gu Q, Xia HH, Wang WH, et al. Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycin. Aliment Pharmacol Ther 2004 20 : 675 81.
28. Feldman M, Cryer B, Mallat D, Go MF. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial. Am J Gastroenterol 2001 96 : 1751 7.
29. Publig W, Wustinger C, Zandl C. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers. Wien Klin Wochenschr 1994 106 : 276 9.
30. Santucci L, Fiorucci S, Patoia L, Di Matteo FM, Brunori PM, Morelli A. Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens. Dig Dis Sci 1995 40 : 2074 80.
31. Yoshida N, Sugimoto N, Hirayama F, Nakamura Y, Ichikawa H, Naito Y, Yoshikawa T. Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils. Gut 2002 50 : 594 8.
32. Tanigawa T, Watanabe T, Hamaguchi M, Sasaki E, Tominaga K, Fujiwara Y, Oshitani N, Matsumoto T, Higuchi K, Arakawa T. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2. Am J Physiol Gastrointest Liver Physiol 2004 286 : G148 56.
33. Futagami S, Hiratsuka T, Wada K, Tatsuguchi A, Tsukui T, Miyake K, Akamatsu T, Hosone M, Sakamoto C, Kobayashi M. Inhibition of Helicobacter pylori-induced cyclo-oxygenase-2 aggravates NSAID-caused gastric damage in Mongolian gerbils. Aliment Pharmacol Ther 2002 16 : 847 55.
34. Takahashi S, Fujita T, Yamamoto A. Role of cyclooxygenase-2 in Helicobacter pylori-induced gastritis in Mongolian gerbils. Am J Physiol Gastrointest Liver Physiol 2000 279 : G791 8.
35. Kim TI, Lee YC, Lee KH, Han JH, Chon CY, Moon YM, Kang JK, Park IS. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity. Infect Immun 2001 69 : 5056 63.
36. Bhang CS, Lee HS, Kim SS, Song HJ, Sung YJ, Kim JI, Chung IS, Sun HS, Park DH, Lee YS. Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter 2002 7 : 14 21.
37. Magari H, Shimizu Y, Inada K, et al. Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils. Biochem Biophys Res Commun 2005 334 : 606 12.
38. Scheiman JM, Greenson JK, Lee J, Cryer B. Effect of cyclooxygenase-2 inhibition on human Helicobacter pylori gastritis: mechanisms underlying gastrointestinal safety and implications for cancer chemoprevention. Aliment Pharmacol Ther 2003 17 : 1535 43.
39. Nam KT, Hahm KB, Oh SY, et al. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Clin Cancer Res 2004 10 : 8105 13.
40. Zaridze D, Borisova E, Maxinovitch D, Chkhikvadze V. Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int J Cancer 1999 82 : 473 6.
41. Akre K, Ekstrom AM, Signorello LB, Hansson LE, Nyren O. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer 2001 84 : 965 8.
42. Konturek PC, Brzozowski T, Kwiecieñ S, Drozdowicz D, Harsch IA, Meixner H, Stachura J, Hahn EG, Konturek SJ. Effect of Helicobacter pylori on delay in ulcer healing induced by aspirin in rats. Eur J Pharmacol 2002 451 : 191 202.
43. McCarthy DM. Helicobacter pylori and NSAIDs - what interaction. Eur J Surg Suppl 2001 586 : 56 65.
44. Elfvin A, Bölin I, Von Bothmer C, Stolte M, Watanabe H, Fändriks L, Vieth M. Helicobacter pylori induces gastritis and intestinal metaplasia but no gastric adenocarcinoma in Mongolian gerbils. Scand J Gastroenterol 2005 40 : 1313 20.
45. Shah AA, Byrne MF, Cullen L, Walsh T, Fitzgerald DJ, Murray FE. Effect of H. pylori infection on the expression of cyclooxygenase-2 in human gastric mucosa. Prostaglandins Leukot Essent Fatty Acids 2003 68 : 1 8.